Product Images Darzalex Faspro
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 2 images provide visual information about the product associated with Darzalex Faspro NDC 57894-503 by Janssen Biotech, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PRINCIPAL DISPLAY PANEL - 15 mL Vial Box - darzalex 01
This is a chart showing the proportion of patients surviving without progression in a clinical trial comparing two treatments (D-Pd vs. Pd). Additionally, it includes the number of patients at risk, median progression-free survival in months, and hazard ratio for each treatment. The numbers represent the amount of time in months.*
darzalex 02
DARZALEX Faspro is an injectable medication containing 1,800mg of daratumumab and 30,000 units of hyaluronidase per 15 mL solution. Each single-dose vial contains inactive ingredients such as histidine hydrochloride, L-methionine, sorbitol, and Water for injection. The medication is administered subcutaneously over 3-5 minutes and is refrigerated at 2°C to 8°C to protect from light. The unused portion of the single-dose vial needs to be discarded.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.